Mesa Nilda — SEC Form 4 filings
SEC reporting owner CIK 1756697. 13 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 13 filings on record, filed 2024-03-29 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 8 filings — 2,388 shares, $887,684 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 645 shares @ $289.99 ($187,045) in UNITED THERAPEUTICS Corp, filed 2025-06-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | Director | 13 | — | 9 legs · 2,388 sh · $887,684 | 14 |
Form 4 filings — Mesa Nilda
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 130 @ $110.86 · Sale (S): 130 @ $505.79 · Sale (S): 98 @ $505.98 · Option exercise (M): 130 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 258 @ $581.93 | EDGAR |
| 2025-12-10 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 187 @ $481.63 | EDGAR |
| 2025-07-28 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 590 @ $0 · Option exercise (M): 590 (derivative) @ $0 · Grant/award (A): 650 (derivative) @ $0 · Grant/award (A): 1,830 (derivative) @ $0 | EDGAR |
| 2025-06-25 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 645 @ $289.99 | EDGAR |
| 2024-12-31 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 255 @ $355.77 | EDGAR |
| 2024-11-12 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 224 @ $412.28 | EDGAR |
| 2024-07-26 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Grant/award (A): 1,440 (derivative) @ $0 · Grant/award (A): 590 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Option exercise (M): 900 @ $0 · Option exercise (M): 900 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 266 @ $318.58 | EDGAR |
| 2024-03-29 | 4 | UNITED THERAPEUTICS Corp (UTHR) | Sale (S): 325 @ $237.80 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756697 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →